Events5th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-5 of the event 5th International Electronic Conference on Medicinal Chemistry
Published date
30 Oct, 2019
Citation
Liliana Raimundo, Margarida Espadinha, Joana Soares, Joana B. Loureiro, Juliana Calheiros, Nair Nazareth, Joana Almeida, Marco G. Alves, Maria M.M Santos, Lucília Saraiva, <span>Improving colon cancer therapy with a new promising small-molecule activator of the p53-pathway through disruption of p53-MDM2/MDMX interactions</span><span></span>, in Proceedings of 5th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2019, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2019-06306
Share
Email
FaceBook
Twitter
Linkedin

Improving colon cancer therapy with a new promising small-molecule activator of the p53-pathway through disruption of p53-MDM2/MDMX interactions

Joana Soares 1
image
image
image
1. LAQV/REQUIMTE, Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
2. Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal
3. Department of Microscopy, Laboratory of Cell Biology, Institute of Biomedical Sciences Abel Salazar & UMIB, Unity for Multidisciplinary Research in Biomedicine, University of Porto, Porto, Portugal
4. LAQV/REQUIMTE, Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
Abstract
Keywords
p53 activation
inhibition of p53-MDM2/MDMX interactions
cancer treatment
Manuscript
Oral Presentation
Poster
sciforum-027809.pdf